Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

NCT06859424 is registered in ClinicalTrials.gov with Center for International Blood and Marrow Transplant Research as lead sponsor.

NCT NCT06859424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06859424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Lead sponsor
Center for International Blood and Marrow Transplant Research
Phase
Phase 2
Overall status
Recruiting
Start date
July 25, 2025
Completion date
June 30, 2028
Enrollment
358 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

acute leukemia (category), acute lymphoid leukemia (all), aml (acute myelogenous leukemia), chronic myelomonocytic leukemia (cmml), cll (chronic lymphocytic leukemia), cml (chronic myelogenous leukemia), lymphoma, mds (myelodysplastic syndrome), myelofibrosis, myeloproliferative neoplasm (mpn), prolymphocyctic leukemia